What is CardioFocus?
CardioFocus specializes in the design and manufacturing of innovative electrophysiology tools, with a primary focus on pulsed field ablation technology. By providing electrophysiologists with advanced catheters and integrated therapy platforms, the company addresses critical unmet needs in cardiac ablation procedures. Their product portfolio is engineered to enhance procedural precision, streamline clinical workflows, and ultimately improve patient outcomes. As a key player in the medical technology landscape, CardioFocus continues to bridge the gap between complex cardiac diagnostics and effective, minimally invasive therapeutic interventions.
How much funding has CardioFocus raised?
CardioFocus has raised a total of $235.3M across 16 funding rounds:
Multiple Rounds
$49.2M
Multiple Rounds
$36.3M
Private Equity
$8M
Private Equity
$20.2M
Debt
$21M
Unspecified
$55M
Debt
$1M
Private Equity (2011): $13.6M, investors not publicly disclosed
Unspecified (2011): $30.6M led by KBL Healthcare Ventures, Manatuck Hill Partners, First Alliance & Capital Invest, H.I.G. Capital, The Aurora Funds, Inc., SV Life Sciences, Accuitive Medical Ventures, Oxford Bioscience Partners, and Fletcher Spaght Ventures
Debt (2011): $5M supported by Silicon Valley Bank
Debt (2014): $2.4M featuring The Aurora Funds, H.I.G. Capital, Fletcher Spaght Ventures, LP, SV Life Sciences, Accuitive Medical Ventures, and Oxford Bioscience Partners
Debt (2014): $2.3M backed by Allied Minds, S.V. Life Sciences, Aurora Funds, Accuitive Medical Ventures, and KBL Healthcare Ventures
Private Equity (2014): $31.7M with participation from Allied Minds, S.V. Life Sciences, Aurora Funds, Accuitive Medical Ventures, KBL Healthcare Ventures, and H.I.G.. BioVentures
Private Equity (2016): $8M led by S.V. Life Sciences, KBL Healthcare Ventures, Allied Minds, H.I.G. BioVentures, Aurora Funds, and Accuitive Medical Ventures
Private Equity (2017): $20.2M, investors not publicly disclosed
Debt (2018): $21M featuring GPB Capital
Unspecified (2019): $55M backed by Kennedy Lewis Investment Management
Debt (2020): $1M with participation from PPP
Key Investors in CardioFocus
SV Health Investors
SV Health Investors is a specialist investment firm backing innovative health care and life science companies, partnering with founders and management to provide capital, sector expertise and active support from early growth through scale and value creation.
Accuitive Medical Ventures
Accuitive Medical Ventures is a market-driven firm looking for revolutionary medical device technology investment opportunities, specializing in venture financing for companies with outstanding technology and teams.
KBL Healthcare Ventures
KBL Healthcare Ventures is focused on investing in innovative healthcare companies that are addressing unmet medical needs, providing financial support and strategic guidance to drive advancements in the sector.
What's next for CardioFocus?
With the support of its latest strategic financing, CardioFocus is well-positioned to accelerate the commercialization of its next-generation ablation platforms. The company's roadmap likely involves deepening its penetration into international markets and investing in clinical research to validate the long-term efficacy of its pulsed field technology. By leveraging its established network of institutional backers and deep-rooted expertise in medical device innovation, CardioFocus is poised to maintain its competitive edge, driving advancements in the treatment of arrhythmias and setting new standards for efficiency in the electrophysiology laboratory.
See full CardioFocus company page
